63.61MMarket Cap-283P/E (TTM)
3.0000High2.8400Low25.56KVolume3.0000Open3.0200Pre Close75.04KTurnover0.24%Turnover Ratio3.24P/E (Static)21.78MShares7.970052wk High2.10P/B31.38MFloat Cap1.590052wk Low--Dividend TTM10.75MShs Float134.0000Historical High--Div YieldTTM5.30%Amplitude1.5900Historical Low2.9350Avg Price1Lot Size
Celularity Stock Forum
NEWS
Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy
Celularity (NASDAQ: CELU) has announced that data published in the Journal for ImmunoTherapy of Cancer highlights the benefits of its placental-derived T-Cell platform for CAR-T therapies. The study revealed that CAR-T cells from Celularity's platform demonstrated greater persistence, resistance to exhaustion, and efficacy compared to tho...
Benzinga· 2 mins ago
Benzinga· 1 min ago
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...
No comment yet